Zhang Zhengyu, Tang Songjia, Huang Zhihui, Tan Juntao, Wu Xiaoxin, Hong Qian, Yuan Yuan
Department of Medical Records, The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou China.
Department of Plastic and Aesthetic Surgery, Affiliated Hangzhou First People's Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China.
Health Sci Rep. 2024 Feb 6;7(2):e1820. doi: 10.1002/hsr2.1820. eCollection 2024 Feb.
Influenza is one of the most widespread respiratory infections and poses a huge burden on health care worldwide. Vaccination is key to preventing and controlling influenza. Influenza vaccine hesitancy is an important reason for the low vaccination rate. In 2019, Vaccine hesitancy was identified as one of the top 10 threats to global health by the World Health Organization. However, there remains a glaring scarcity of bibliometric research in that regard. This study sought to identify research hotspots and future development trends on influenza vaccine hesitation and provide a new perspective and reference for future research.
We retrieved publications on global influenza vaccine hesitancy from the Web of Science Core Collection database, Scopus, and PubMed databases from inception to 2022. This study used VOSviewer and CiteSpace for visualization analysis.
Influenza vaccine hesitancy-related publications increased rapidly from 2012 and peaked in 2022. One hundred and nine countries contributed to influenza vaccine hesitation research, and the United States ranked first with 541 articles and 7161 citations. was the journal with the largest number of published studies on influenza vaccine hesitations. MacDonald was the most frequently cited author. The most popular research topics on influenza vaccine hesitancy were (1) determinants of influenza vaccination in specific populations, such as healthcare workers, children, pregnant women, and so on; (2) influenza and COVID-19 vaccine hesitancy during the COVID-19 pandemic.
The trend in the number of annual publications related to influenza vaccine hesitancy indicating the COVID-19 pandemic will prompt researchers to increase their attention to influenza vaccine hesitancy. With healthcare workers as the key, reducing vaccine hesitancy and improving vaccine acceptance in high-risk groups will be the research direction in the next few years.
流感是最广泛传播的呼吸道感染之一,给全球医疗保健带来巨大负担。接种疫苗是预防和控制流感的关键。对流感疫苗的犹豫是疫苗接种率低的一个重要原因。2019年,疫苗犹豫被世界卫生组织确定为全球健康面临的十大威胁之一。然而,在这方面的文献计量研究仍然明显匮乏。本研究旨在确定流感疫苗犹豫的研究热点和未来发展趋势,为未来研究提供新的视角和参考。
我们从Web of Science核心合集数据库、Scopus和PubMed数据库中检索了从数据库建立到2022年关于全球流感疫苗犹豫的出版物。本研究使用VOSviewer和CiteSpace进行可视化分析。
与流感疫苗犹豫相关的出版物从2012年开始迅速增加,并在2022年达到峰值。109个国家参与了流感疫苗犹豫研究,美国以541篇文章和7161次引用排名第一。 是发表关于流感疫苗犹豫研究最多的期刊。麦克唐纳是被引用次数最多的作者。关于流感疫苗犹豫最热门的研究主题是:(1)特定人群(如医护人员、儿童、孕妇等)接种流感疫苗的决定因素;(2)新冠疫情期间流感和新冠疫苗犹豫。
与流感疫苗犹豫相关的年度出版物数量趋势表明,新冠疫情将促使研究人员增加对流感疫苗犹豫的关注。以医护人员为重点,减少疫苗犹豫并提高高危人群的疫苗接受度将是未来几年的研究方向。